Core Scientific (NASDAQ:CORZ) versus Portage Biotech (NASDAQ:ALP) Critical Contrast

Portage Biotech (NASDAQ:ALP) and Core Scientific (NASDAQ:CORZ) are both technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Volatility and Risk

Portage Biotech has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500. Comparatively, Core Scientific has a beta of 5.48, indicating that its share price is 448% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Portage Biotech and Core Scientific, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1	2	0	0	1.67
Core Scientific	1	2	18	2	2.91

Portage Biotech presently has a consensus price target of $12.50, suggesting a potential upside of 131.05%. Core Scientific has a consensus price target of $30.86, suggesting a potential upside of 71.83%. Given Portage Biotech’s higher probable upside, research analysts clearly believe Portage Biotech is more favorable than Core Scientific.

Profitability

This table compares Portage Biotech and Core Scientific’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Core Scientific	-325.50%	N/A	-9.64%

Insider & Institutional Ownership

13.4% of Portage Biotech shares are held by institutional investors. 1.7% of Core Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Portage Biotech and Core Scientific”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$100,000.00	83.86	-$38.63 million	($409.00)	-0.01
Core Scientific	$319.02 million	18.09	-$288.62 million	($4.42)	-4.06

Portage Biotech has higher earnings, but lower revenue than Core Scientific. Core Scientific is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks.

About Portage Biotech

Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company’s product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.

About Core Scientific

Core Scientific, Inc. provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment. In addition, the company provides electrical power, repair, and other infrastructure services to operate, maintain, and earn digital assets; and sells mining equipment to customers. Core Scientific, Inc. was founded in 2017 and is headquartered in Dover, Delaware.